Madison PoliceJanice Frost Wells, 39, is accused of stealing a pain patch from a nursing home patient. MADISON, Ala. -- Investigators are looking for a woman who has been allegedly sneaking into nursing homes and stealing pain patches from patients....

A hostage standoff at an O'Fallon medical building in November ended with two people dead and three sons - ages 17, 21 and 22 - without their mother.

YM BioSciences Inc. , an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced that it has received clearance from Canadian regulatory authorities to initiate two Phase II, double-blind, randomized trials for nimotuzumab, its EGFR-targeting antibody, in combination with radiation-based treatments.

YM BioSciences Inc. , an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced that it has received clearance from Canadian regulatory authorities to initiate two Phase II, double-blind, randomized trials for nimotuzumab, its EGFR-targeting antibody, in combination with radiation-based treatments.

YM BioSciences Inc. , an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced that the National Cancer Centre of Singapore has selected nimotuzumab, YM's EGFR-targeting drug, for evaluation in a multinational Phase III trial of more than 700 patients with cancers of the head and neck.

BioDelivery Sciences International, Inc. (Nasdaq: BDSI) and Meda AB today announced an expansion of their commercial partnership that provides Meda with worldwide exclusive rights to distribute the company’s lead product candidate ONSOLIS™, a treatment for breakthrough pain in opioid tolerant patients with cancer. The transaction will give Meda exclusive rights to distribute ONSOLIS in all ...

RALEIGH, N.C.----BioDelivery Sciences International, Inc. and Meda AB today announced an expansion of their commercial partnership that provides Meda with worldwide exclusive rights to distribute the company’s lead product candidate ONSOLIS™, a treatment for breakthrough pain in opioid tolerant patients with cancer.

PriCara, a division of Ortho-McNeil-Janssen Pharmaceuticals, has announced that one lot of 50mcg/hr Duragesic CII patches sold by PriCara in the US and one lot of 50mcg/hr fentanyl patches sold by Sandoz in the US are being voluntarily recalled as a precaution from wholesalers and pharmacies.

A hostage standoff at an O'Fallon medical building in November ended with two people dead and three sons - ages 17, 21 and 22 - without their mother.

A hostage standoff at an O'Fallon medical building in November ended with two people dead and three sons - ages 17, 21 and 22 - without their mother.